StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Unrecognized Stock-Based Compensation Expense by Year

Unrecognized Stock-Based Compensation Expense — RSUs & Options ($M) ($M)

Natera Unrecognized Stock-Based Compensation Expense: $637M in FY2025, up 25.0% from a year earlier. That is the highest of the 8 years on record here.

Latest, FY2025
637
Period ended Dec 31, 2025
Change on a year earlier
+25.0%
509 in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (2026-02-27) ↗

Reported in Form 10-K Note — Stock-Based Compensation (XBRL).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedUnrecognized Stock-Based Compensation Expense — RSUs & Options ($M) ($M)Year on yearSource
FY2025Dec 31, 2025637+25.0%Form 10-K (2026-02-27) ↗
FY2024Dec 31, 2024509+53.7%Form 10-K (2025-02-28) ↗
FY2023Dec 31, 2023332+25.0%Form 10-K (2024-02-29) ↗
FY2022Dec 31, 2022265+13.6%Form 10-K (2023-03-01) ↗
FY2021Dec 31, 2021233+97.0%Form 10-K (2022-02-25) ↗
FY2020Dec 31, 2020118+135.9%Form 10-K (2021-02-26) ↗
FY2019Dec 31, 201950.2+102.4%Form 10-K (2020-03-02) ↗
FY2018Dec 31, 201824.8–Form 10-K (2019-03-15) ↗

Cite this data

StockData. (2026). Natera Unrecognized Stock-Based Compensation Expense ($M), annual FY2018–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/sbc-unrecognized-cost

See every metric in the Natera KPI table. Data updated Nov 2, 2026.